UNSPSC 51171715: Bismuth subgallate

This classification denotes a topical anti-infective agent with the molecular formula C7H4O5.Bi.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YIW503MI7V, chemically known as 1,3,2-benzodioxabismole-5-carboxylic acid, 2,7-dihydroxy- but generally known as bismuth subgallate, which bears US NIH Compound Identifier 16682999. European Medicines Agency schedules Bismuth subgallate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13091MIG.

As of Q4 2014, BISMUTH SUBGALLATE remains the US FDA Preferred Term for this commodity. Bismuth subgallate bears US NLM identifiers UMLS ID C0053790 and NCI Concept Code C77029. SMILES: [Bi]1(Oc2c(O1)cc(cc2O)C(=O)O)[OH2].

UNSPSC 51171715 Bismuth subgallate is a Commodity code that in recent state and local procurement activity describes pharmaceutical and laboratory testing materials used in offender drug screening and specimen collection operations. The recent opportunity under this code shows that state and local corrections and community supervision departments are purchasing testing supplies, reagents, and related materials necessary to conduct immunoassay screening, confirmation testing via LC/MS/MS or GC/MS, and alternative testing methodologies including oral fluid and hair analysis. Issuing bodies soliciting under this code include county community supervision and corrections departments responsible for probation and offender monitoring.

Collin County Community Supervision and Corrections Department (Texas) posted RFP 2026-327 on September 25, 2026, soliciting offender specimen collection and drug testing services with an estimated contract value of $600,000 and proposals due July 23, 2026 at 2:00 p.m. The RFP calls for staffing two collection sites in Plano and McKinney, operation of an Interactive Voice Response system for randomized testing notifications, and laboratory testing capacity for approximately 25,031 tests annually comprising five-panel and six-panel screens with confirmation capability. The successful vendor must maintain SAMHSA, Texas Department of Public Safety, or CAP lab certification. The contract term runs two years commencing September 1, 2026, with three optional one-year renewal periods not to exceed five years total, and the anticipated award date is August 10, 2026.